(Q35613504)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

review article

1 reference

title

Docetaxel in advanced gastric cancer--review of the main clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Nicola Fazio

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

4

Nicola Silvestris

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

2

Gianluigi Ferretti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

author name string

Paolo Carlini

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Andrea Alimonti

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Alain Gelibter

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Alessandra Felici

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Paola Papaldo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

Francesco Cognetti

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

language of work or name

1 reference

1 January 2003

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

number of pages

8

1 reference

based on heuristic

inferred from page(s)

published in

Acta Oncologica

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

volume

42

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

page(s)

693-700

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:14690154%20AND%20SRC:MED&resulttype=core&format=json

16 November 2019

cites work

Cancer statistics, 2003.

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

21 January 2018

Cancer statistics, 1999.

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

The taxoids: paclitaxel (Taxol) and docetaxel (Taxotere).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Taxol stabilizes microtubules in mouse fibroblast cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Docetaxel 75 mg/m(2) is active and well tolerated in patients with metastatic or recurrent gastric cancer: a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Chemotherapy in gastric cancer: a never ending saga.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Frontline treatment of advanced gastric cancer with docetaxel and granulocyte colony-stimulating factor (G-CSF): a phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Combination chemotherapy with docetaxel and cisplatin for locally advanced and metastatic gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Long-term survival after epirubicin, cisplatin and fluorouracil for gastric cancer: results of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

A systematic overview of chemotherapy effects in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Is òne cycle every three or four weeks' obsolete? A critical review of dose-dense chemotherapy in solid neoplasms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

A phase II study of weekly docetaxel as salvage chemotherapy for advanced gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014

Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F02841860310011014